A unit of Bausch & Lomb pled guilty recently to a felony and was excluded from Medicare and Medicaid. A unit of ISTA Pharmaceuticals, Bausch & Lomb, pled guilty to a felony charge of... Read more
The U.S. Supreme Court has ruled that drugmakers can be sued for paying rivals to delay low-cost versions of popular medicines. The high court, in a decision last month, has rewritten the ru... Read more
As deaths continue to climb in the ongoing outbreak of fungal meningitis infections caused by contaminated pain shots, a new survey of hospital pharmacists shows that they believe it could h... Read more
Most Americans would be shocked if they knew that the politically powerful pharmaceutical industry has seen almost all of its companies accused of fraud at some point in time by both the fed... Read more
The Obama Administration is proposing legislation that would require pharmaceutical companies to disclose payments made to doctors for research, consulting, speaking, traveling and entertain... Read more
Swiss pharmaceutical company Roche Group has suspended a late-stage trial for a new rheumatoid arthritis and lupus drug after several patients died from infections. According to Roche, the d... Read more
A Circuit Court jury in Montgomery County, Alabama, on February 24th returned a verdict in favor of the State of Alabama against Sandoz, the drug manufacturer. Sandoz was found guilty of def... Read more
A federal judge in Boston has certified two nationwide classes and set the stage for two more trials in the massive, multidistrict wholesale drug pricing case against AstraZeneca and Bristol... Read more
Eli Lilly & Co. will pay $62 million to resolve claims relating to the marketing and promotion of its anti-psychotic drug Zyprexa to patients who did not have schizophrenia or bipolar d... Read more
The Massachusetts Attorney General’s Office has reached a settlement with Boehringer Ingelheim Roxane, Inc. (Roxane), a Columbus, Ohio-based drug manufacturer, in a False Claims Act case. Un... Read more
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.